Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1432
https://www.valueinhealthjournal.com/article/S1098-3015(14)03362-2/fulltext
Title : Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03362-2&doi=10.1016/j.jval.2014.08.1432
First page : A487
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 911
Categories :
Tags :
Regions :
ViH Article Tags :